Literature DB >> 15062572

TSH-activated signaling pathways in thyroid tumorigenesis.

Marcos Rivas1, Pilar Santisteban.   

Abstract

Thyrotropin (TSH) is considered the main regulator of thyrocyte differentiation and proliferation. Thus, the characterization of the different signaling pathways triggered by TSH on these cells is of major interest in order to understand the mechanisms implicated in thyroid pathology. In this review we focus on the different signaling pathways involved in TSH-mediated proliferation and their role in thyroid transformation and tumorigenesis. TSH mitogenic activities are mediated largely by cAMP, which in turn may activate protein kinase (PKA)-dependent and independent processes. We analyze the effects of increased cAMP levels and PKA activity during cell cycle progression and the role of this signaling pathway in thyroid tumor initiation. Alternative pathways to PKA in the cAMP-mediated proliferation appear to involve the small GTPases Rap1 and Ras. We analyze the Ras effectors (PI3K, RalGDS and Raf) that are thought to mediate its oncogenic activity, as well as the ability of Ras to induce apoptosis in thyrocytes. Finally, we discuss the activation of the PLC/PKC cascade by TSH in thyroid cells and the role of this signaling pathway in the TSH-mediated proliferation and tumorigenesis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 15062572     DOI: 10.1016/j.mce.2003.10.029

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  33 in total

1.  Embryonic epithelial Pten deletion through Nkx2.1-cre leads to thyroid tumorigenesis in a strain-dependent manner.

Authors:  Saverio Bellusci; Parviz Minoo; Caterina Tiozzo; Soula Danopoulos; Maria Lavarreda-Pearce; Sheryl Baptista; Radka Varimezova; Denise Al Alam; David Warburton; Rehan Virender; Stijn De Langhe; Antonio Di Cristofano
Journal:  Endocr Relat Cancer       Date:  2012-04-10       Impact factor: 5.678

Review 2.  Tyrosine kinase inhibitor-induced hypothyroidism: incidence, etiology, and management.

Authors:  Rebecca L Brown
Journal:  Target Oncol       Date:  2011-11-19       Impact factor: 4.493

3.  Cyclic AMP inhibits the proliferation of thyroid carcinoma cell lines through regulation of CDK4 phosphorylation.

Authors:  Ana Sofia Rocha; Sabine Paternot; Katia Coulonval; Jacques E Dumont; Paula Soares; Pierre P Roger
Journal:  Mol Biol Cell       Date:  2008-09-17       Impact factor: 4.138

Review 4.  Constitutive activation of G protein-coupled receptors and diseases: insights into mechanisms of activation and therapeutics.

Authors:  Ya-Xiong Tao
Journal:  Pharmacol Ther       Date:  2008-08-09       Impact factor: 12.310

5.  Switch in signaling control of mTORC1 activity after oncoprotein expression in thyroid cancer cell lines.

Authors:  Roberta Malaguarnera; Kuen-Yuan Chen; Tae-Yong Kim; Jose M Dominguez; Francesca Voza; Bin Ouyang; Sushil K Vundavalli; Jeffrey A Knauf; James A Fagin
Journal:  J Clin Endocrinol Metab       Date:  2014-07-16       Impact factor: 5.958

6.  cAMP-dependent activation of mammalian target of rapamycin (mTOR) in thyroid cells. Implication in mitogenesis and activation of CDK4.

Authors:  Sara Blancquaert; Lifu Wang; Sabine Paternot; Katia Coulonval; Jacques E Dumont; Thurl E Harris; Pierre P Roger
Journal:  Mol Endocrinol       Date:  2010-05-19

7.  A case of primary thyroid squamous cell cancer: transformation from benign tumour associated with chronic thyroiditis?

Authors:  Tatsuya Kondo; Akiko Matsuyoshi; Hidetake Matsuyoshi; Rieko Goto; Kaoru Ono; Yumi Honda; Ken-Ichi Iyama; Kaku Tsuruzoe; Nobuhiro Miyamura; Eiichi Araki
Journal:  BMJ Case Rep       Date:  2009-04-14

8.  PTEN deficiency accelerates tumour progression in a mouse model of thyroid cancer.

Authors:  C J Guigon; L Zhao; M C Willingham; S-Y Cheng
Journal:  Oncogene       Date:  2008-11-10       Impact factor: 9.867

9.  Prolonged chronic graft-versus-host disease is a risk factor for thyroid failure in long-term survivors after matched sibling donor stem cell transplantation for hematologic malignancies.

Authors:  Bipin N Savani; Eleftheria K Koklanaris; Quan Le; Aarthi Shenoy; Stacey Goodman; A J Barrett
Journal:  Biol Blood Marrow Transplant       Date:  2009-03       Impact factor: 5.742

Review 10.  Modeling thyroid cancer in the mouse.

Authors:  X-G Zhu; S-Y Cheng
Journal:  Horm Metab Res       Date:  2009-04-08       Impact factor: 2.936

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.